FOXD2 and laryngeal carcinoma: Results showed that the FOXD2 mRNA levels did not change in response to alterations in FOXD2-AS1 expression (Fig. 5c), suggesting FOXD2-AS1 would not act as a cis-regulator in laryngeal cancer.